Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
This 1 Simple ETF Could Turn $100 a Month Into $93,200

Turn small investments into big returns with this surprisingly simple strategy -- and a hands-off ETF investment for the ages.

LLY : 771.55 (-0.45%)
VUG : 344.00 (+0.34%)
$SPX : 5,214.08 (+0.51%)
Why Eli Lilly Stock Jumped by 4% Today

The company's payout is far from the only reason investors like the stock these days, but it certainly helps.

LLY : 771.55 (-0.45%)
2 Top Stocks That Could Make You Richer in 2024

Here are a couple of great ideas on where to invest your money today.

GOOGL : 169.96 (+0.34%)
GOOG : 171.58 (+0.25%)
LLY : 771.55 (-0.45%)
3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years

These stocks have rock-solid businesses and they have impressive track records for paying dividends.

LLY : 771.55 (-0.45%)
KO : 62.88 (+0.05%)
TD : 56.13 (+0.21%)
3 No-Brainer Stocks to Buy in May

These great stocks are great picks for investors as spring winds down.

LLY : 771.55 (-0.45%)
PFE : 28.18 (+1.18%)
VRTX : 418.99 (+0.04%)
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making

Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.

JPM : 197.50 (+0.95%)
LLY : 771.55 (-0.45%)
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.

LLY : 771.55 (-0.45%)
PFE : 28.18 (+1.18%)
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?

The anti-obesity medication stock is way up, and there could be more fuel in the tank.

NVO : 128.66 (+1.55%)
VKTX : 80.20 (+0.36%)
LLY : 771.55 (-0.45%)
Why Amgen Stock Zoomed Nearly 12% Higher Today

The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop.

NVO : 128.66 (+1.55%)
LLY : 771.55 (-0.45%)
AMGN : 312.86 (+1.81%)
This Is a Huge Sigh of Relief for Novo Nordisk Investors

The path is clear for even more growth from Novo Nordisk's top two drugs, Ozempic and Wegovy.

LLY : 771.55 (-0.45%)
NVO : 128.66 (+1.55%)

Barchart Exclusives

1 Dividend Aristocrat to Buy for Double-Digit Earnings Growth
Discover why Ecolab's recent earnings beat, along with its robust dividend history, make it a standout choice for investors seeking a blend of growth and stability in 2024. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar